0000899243-23-004062.txt : 20230206 0000899243-23-004062.hdr.sgml : 20230206 20230206171655 ACCESSION NUMBER: 0000899243-23-004062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacBeath Gavin CENTRAL INDEX KEY: 0001738082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23591545 MAIL ADDRESS: STREET 1: C/O ABPRO CORPORATION STREET 2: 65 CUMMINGS PARK DRIVE CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-02 0 0001783328 TScan Therapeutics, Inc. TCRX 0001738082 MacBeath Gavin C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 See Remarks Stock Option (Right to Buy) 1.81 2023-02-02 4 A 0 40000 0.00 A 2033-02-01 Voting Common Stock 40000 40000 D The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. Chief Scientific and Operations Officer /s/ Gavin MacBeath 2023-02-06